|
RHBDD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63840000000359E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12760000003931E-06 |
| Normal-vs-Stage2 |
1.892340E-02 |
| Normal-vs-Stage3 |
3.883700E-02 |
| Normal-vs-Stage4 |
2.603600E-01 |
| Stage1-vs-Stage2 |
5.509200E-01 |
| Stage1-vs-Stage3 |
3.115600E-01 |
| Stage1-vs-Stage4 |
6.273800E-01 |
| Stage2-vs-Stage3 |
7.811800E-01 |
| Stage2-vs-Stage4 |
9.580200E-01 |
| Stage3-vs-Stage4 |
8.896600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.94150000001991E-06 |
| Normal-vs-AfricanAmerican |
1.198360E-04 |
| Normal-vs-Asian |
3.984100E-03 |
| Caucasian-vs-AfricanAmerican |
7.763000E-01 |
| Caucasian-vs-Asian |
7.236800E-01 |
| AfricanAmerican-vs-Asian |
7.807800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.47020000010423E-08 |
| Normal-vs-Female |
2.187000E-01 |
| Male-vs-Female |
2.743800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.630600E-04 |
| Normal-vs-Extreme_Weight |
5.29679999861088E-08 |
| Normal-vs-Obese |
1.645610E-02 |
| Normal-vs-Extreme_Obese |
1.434440E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.460800E-01 |
| Normal_Weight-vs-Obese |
2.179200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.696400E-01 |
| Extreme_Weight-vs-Obese |
1.944390E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.986400E-01 |
| Obese-vs-Extreme_Obese |
3.016800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.506400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.558500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.4644000002082E-08 |
| Normal-vs-Age(81-100Yrs) |
7.65620000000578E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.802000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.329700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.897800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.791760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.901150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.813600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11910000044624E-07 |
| Normal-VS-Type2 PRCC |
2.018200E-04 |
| Normal-VS-KIRP CIMP |
3.754400E-01 |
| Normal-VS-Unclassified PRCC |
3.142000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.634000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.036700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.783740E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.039860E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.004440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.886380E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46619999996656E-06 |
| Normal-vs-N1 |
1.914790E-01 |
| Normal-vs-N2 |
7.007000E-01 |
| N0-vs-N1 |
4.302200E-02 |
| N0-vs-N2 |
2.953400E-01 |
| N1-vs-N2 |
2.721600E-01 |
|
|
